Cargando…
Calcitonin gene-related peptide antagonists versus botulinum toxin A for the preventive treatment of chronic migraine protocol of a systematic review and network meta-analysis: A protocol for systematic review
BACKGROUND: Although calcitonin gene-related peptide antagonists and botulinum toxin A have been shown efficacy in preventing chronic migraine, there is no direct evidence for their comparative effectiveness. This review is to assess the comparative effectiveness and safety of calcitonin gene-relate...
Autores principales: | She, Tianwei, Chen, Yaoyao, Tang, Taichun, Chen, Min, Zheng, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004656/ https://www.ncbi.nlm.nih.gov/pubmed/32000407 http://dx.doi.org/10.1097/MD.0000000000018929 |
Ejemplares similares
-
Calcitonin gene-related peptide receptor antagonist ubrogepant for the treatment of acute migraine: A meta-analysis
por: Zhang, Zizhen, et al.
Publicado: (2021) -
The functional alterations in primary migraine: A systematic review and meta-analysis protocol
por: Xu, Guixing, et al.
Publicado: (2020) -
Recent advances in targeting calcitonin gene-related peptide for the treatment of menstrual migraine: A narrative review
por: Jiang, Yan, et al.
Publicado: (2022) -
Retinal nerve fiber layer changes in migraine: A protocol for systematic review and meta-analysis
por: Lin, XiaoGuang, et al.
Publicado: (2020) -
Different Chinese patent medicine therapies for migraine: A protocol for systematic review and network meta-analysis
por: Hu, Liangen, et al.
Publicado: (2021)